October 12, 2017
BioTime (NYSEMKT: BTX) proposes 9.515 M share offering
September 20, 2017
Juno Therapeutics (JUNO) proposes $225 M follow-on offering
June 20, 2017
Sangamo Therapeutics (SGMO) proposes $72.5 M offering
February 9, 2017
BioTime (NYSEMKT: BTX) Proposes offering of 6.48 M shares at $2.70
December 15, 2016
Vericel (VCEL) proposes 6.2 M share $17 M offering at $2.75
October 27, 2016
TiGenix NV (Euronext Brussels: TIG) proposes U.S. IPO
October 6, 2016
AxoGen (AXGN) proposes offering of 2.33 M shares priced at $7.50
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at email@example.com.
Editor and Publisher ... Henry McCusker enters his thirteenth (13th) year at RegMed Investors